Clinical Trial Update: Creatine Augmentation in Veterans With SSRI-Resistant Major Depression [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating creatine augmentation in veterans with SSRI-resistant major depression has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: University of Utah | Conditions: Major Depressive Disorder | Phase 4 | Status: WITHDRAWN